Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety.
about
Psychological and pharmacological interventions for depression in patients with coronary artery diseaseAntidepressants for depression in physically ill peopleDepression and the Link with Cardiovascular DiseaseCardiovascular risk assessment in patients with a severe mental illness: a systematic review and meta-analysisBehavioural screening of zebrafish using neuroactive traditional Chinese medicine prescriptions and biological targets.A systematic review of duloxetine and venlafaxine in major depression, including unpublished data.Prevalence of antidepressant prescription or use in patients with acute coronary syndrome: a systematic review.Effects of antidepressants on IP-10 production in LPS-activated THP-1 human monocytes.Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 BalanceChanges in heart rate variability of depressed patients after electroconvulsive therapySerotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis.Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care databaseComorbidity clusters in autism spectrum disorders: an electronic health record time-series analysisIdentifying and managing factors that interfere with or worsen blood pressure control.Adverse reactions to duloxetine in depression.The cost effectiveness of pharmacological treatments for generalized anxiety disorder.A review of the adverse effects and safety of noradrenergic antidepressants.The value of drug and metabolite concentration in blood as a biomarker of psychopharmacological therapy.Cardiovascular adverse effects of newer antidepressants.Risk-benefit analysis of antidepressant drug treatment in the elderly.Is Mania the Hypertension of the Mood? Discussion of A Hypothesis.Changes in cardiovascular function after venlafaxine but not pregabalin in healthy volunteers: a double-blind, placebo-controlled study of orthostatic challenge, blood pressure and heart rate.Comparative drug dose and drug combinations in patients that present to hospital due to self-poisoning.Carotid atherosclerosis in depression and anxiety: associations for age of depression onset.Plasma sphingolipids and depressive symptoms in coronary artery disease.Depression in adults: drug and physical treatments
P2860
Q24234331-5FC9446A-8E4E-46C4-B1DD-638625AEDEF9Q24236616-BA69AE03-C5C6-45ED-9E3E-69348D07C9C3Q26752379-BB2BE00E-056D-4890-893D-2075319E5993Q28066750-6E88F114-AC47-4C08-8666-F5CC69236CBAQ30580754-7B2F4B50-027D-489E-967B-7941294002C3Q33689953-DF816B46-645B-4647-A28D-2D1A0BD949EDQ34087791-F28FBB52-2153-4C88-9390-D5DAD0EBE8EFQ34158301-A5D6950D-861B-4822-9960-72CB60268515Q36067334-3ECCB596-D524-49CC-97BA-5FD7E3763235Q36206513-81BCA936-91E5-4349-A6D1-1E5ABC2DE3E1Q36576591-9D8C5C1D-D585-4152-9FE0-BAAA6D5240BDQ36719034-974EAB33-76A2-4C76-A1CB-049F1C49CC0BQ37421126-76E7E086-20C2-4654-A5D1-FF9F738A1A98Q37702724-06BE3141-6242-4D99-9754-530DFBF7043FQ37872294-DCBAD67D-011E-4363-91A9-BC8621ACDE86Q38091323-9C672453-FF74-4158-B43E-2E301F5CEAE4Q38115737-D528FB0D-0BC0-4453-BE52-4E150537BEA7Q38154910-382EDA2F-6214-4850-8B13-9019F7D08FF6Q38205025-3B67F210-660A-49D2-840C-FEAF8720133DQ38286201-A5548D54-BCF0-412F-A064-1256DFF79D6CQ39305705-E1E10998-DF8D-420C-899D-D46CF21F3B17Q43848135-47153317-38E1-4C22-97E6-291F58274D3EQ43975024-90FA5AB4-7DB8-4AD7-9A0A-EE1E26864527Q44123900-3C6EDEF0-B04F-4356-B2D1-6A3C94A97B03Q46248790-E2B5E75D-44D2-4404-A8BA-1430BA4BE273Q57542376-E13B5D03-312B-4CC7-801D-72D2B4365164
P2860
Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Antidepressant drugs and cardi ...... w of effectiveness and safety.
@ast
Antidepressant drugs and cardi ...... w of effectiveness and safety.
@en
Antidepressant drugs and cardi ...... w of effectiveness and safety.
@nl
type
label
Antidepressant drugs and cardi ...... w of effectiveness and safety.
@ast
Antidepressant drugs and cardi ...... w of effectiveness and safety.
@en
Antidepressant drugs and cardi ...... w of effectiveness and safety.
@nl
prefLabel
Antidepressant drugs and cardi ...... w of effectiveness and safety.
@ast
Antidepressant drugs and cardi ...... w of effectiveness and safety.
@en
Antidepressant drugs and cardi ...... w of effectiveness and safety.
@nl
P2860
P1476
Antidepressant drugs and cardi ...... w of effectiveness and safety.
@en
P2860
P304
P356
10.1111/J.1600-0447.2008.01260.X
P407
P50
P577
2008-09-08T00:00:00Z